What is King Pharmaceuticals's interest paid?

King Pharmaceuticals (KG) reported interest paid of $2.83M in Q4 2025.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

King Pharmaceuticals KG Interest Paid

Interest Paid at other companies

Arch Capital GroupACGL

$0—

Everest GroupEG

$35M+119%

KKR & Co.KKR

$807.71M+34.0%

Skyward Specialty Insurance Group, Inc.SKWD

$6.25M+246%

Reinsurance Group of AmericaRGA

$87M+42.6%

Verisk Analytics, Inc.VRSK

$60M+477%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's interest paid?: King Pharmaceuticals (KG) reported interest paid of $2.83M in Q4 2025.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.